CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.

Makovec A, Boytim E, Gustafson A, Ludwig M, Wang L, Ali A, Ishani K, Luo C, Bergom HE, John E, Tape S, Kellen S, Deacon A, Dewji FI, Richter C, Cookle L, Moline D, Rennhack JP, Drake JM, Antonarakis ES, Largaespada DA, Ostrander JH, Hwang J

Open source

DOI: 10.1038/s41698-025-01051-z
Published: 2025 Aug 6
Container: NPJ precision oncology
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41698-025-01051-z,
  title = {CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.},
  author = {Makovec A and Boytim E and Gustafson A and Ludwig M and Wang L and Ali A and Ishani K and Luo C and Bergom HE and John E and Tape S and Kellen S and Deacon A and Dewji FI and Richter C and Cookle L and Moline D and Rennhack JP and Drake JM and Antonarakis ES and Largaespada DA and Ostrander JH and Hwang J},
  year = {2025},
  journal = {NPJ precision oncology},
  doi = {10.1038/s41698-025-01051-z},
  url = {https://doi.org/10.1038/s41698-025-01051-z}
}

RIS

TY  - JOUR
TI  - CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.
AU  - Makovec A
AU  - Boytim E
AU  - Gustafson A
AU  - Ludwig M
AU  - Wang L
AU  - Ali A
AU  - Ishani K
AU  - Luo C
AU  - Bergom HE
AU  - John E
AU  - Tape S
AU  - Kellen S
AU  - Deacon A
AU  - Dewji FI
AU  - Richter C
AU  - Cookle L
AU  - Moline D
AU  - Rennhack JP
AU  - Drake JM
AU  - Antonarakis ES
AU  - Largaespada DA
AU  - Ostrander JH
AU  - Hwang J
PY  - 2025
JO  - NPJ precision oncology
DO  - 10.1038/s41698-025-01051-z
UR  - https://doi.org/10.1038/s41698-025-01051-z
ER  -

APA

A, M., E, B., A, G., M, L., L, W., A, A., K, I., C, L., HE, B., E, J., S, T., S, K., A, D., FI, D., C, R., L, C., D, M., JP, R., JM, D., ES, A., DA, L., JH, O., & J, H. (2025). CREB5 promotes tumorigenicity and upregulates druggable cell surface modalities in basal-like breast cancer.. NPJ precision oncology. https://doi.org/10.1038/s41698-025-01051-z

Source records

pubmed · retrieved 2026-09-27T06:23:39.776Z
europe-pmc · retrieved 2026-09-27T06:23:39.776Z
doaj · retrieved 2026-09-27T06:23:39.786Z